Data4cure Poland sp. z o.o.

Computer programming activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2020-05-28
Share capital
5,000.00 PLN
Activity description

Data4cure Poland is a company that provides the Biomedical Intelligence® Cloud and CURIE Knowledge Graph™ to pharmaceutical and biotech organizations for drug development. They specialize in data integration, advanced analysis, and knowledge synthesis to support decision-making throughout the research process. Their platform facilitates the analysis of complex biomedical data, including omics and clinical data, to uncover novel insights and relationships.

Registered address
ul. Puławska 2, 02-566 Warszawa, Poland
Email
Social media

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$8,120
Profit allocationNo decision
Loans and borrowings$25,175
Related parties1 items
Parent companyDATA4CURE INC

Filing timeliness

Financial statements were filed on time, on average 43 days early.

  • 202501/07/2026
  • 202423/06/2025
  • 202306/06/2024
  • 202215/06/2023
  • 202120/06/2022
  • 202011/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Computer programming activities1,404 / 11,174
Top 13%
Sector · Information and communication2,419 / 21,342
Top 11%
City · Warszawa11,738 / 56,772
Top 21%
Voivodeship · Mazowieckie16,586 / 76,953
Top 22%
Country · Poland64,830 / 297,266
Top 22%

Results vs industry

Revenue
This companyUSD 1.82mMedianUSD 120.54kAverageUSD 1.77m
Net profit
This companyUSD 79.52kMedianUSD 2.92kAverageUSD 23.81k
Operating costs
This companyUSD 1.73mMedianUSD 112.29kAverageUSD 1.69m
Assets
This companyUSD 2.42mMedianUSD 79.64kAverageUSD 1.14m

News

Driving AI-powered drug discovery in partnership with Pfizer (videos from PMWC 2025)

Driving AI-powered drug discovery in partnership with Pfizer (videos from PMWC 2025)

Recap of Data4Cure's PMWC 2025 session on knowledge graphs, LLMs and foundation models in pharmaceutical R&D — featuring Pfizer's Paul Rejto and Data4Cure CEO Janusz Dutkowski, and the Data4Cure–Pfizer partnership.

In the News: Drug Information Association's Magazine

In the News: Drug Information Association's Magazine

Data4Cure's article on Using Semantic AI in Biomedicine appears in the July 2019 issue of the Drug Information Association (DIA) Global Forum Magazine.

Join us at the 2020 Precision Medicine World Conference (PMWC)

Join us at the 2020 Precision Medicine World Conference (PMWC)

Data4Cure is part of the 2020 Precision Medicine World Conference, the largest annual conference dedicated to precision medicine.

Knowledge Graph-based Eco-System for Pharmaceutical R&D (PMWC 2023)

Knowledge Graph-based Eco-System for Pharmaceutical R&D (PMWC 2023)

Data4Cure took part in the 2023 Precision Medicine World Conference in Santa Clara, where CEO Janusz Dutkowski gave a talk on a knowledge-graph-based ecosystem for pharmaceutical R&D.

Knowledge graphs and AI for drug discovery and development (PMWC 2025)

Knowledge graphs and AI for drug discovery and development (PMWC 2025)

Data4Cure CEO Janusz Dutkowski hosts a PMWC 2025 session with Pfizer's Paul Rejto on knowledge graphs and foundation models for enhanced drug development, and the newly announced Data4Cure–Pfizer partnership.

Pharmaceutical companies adopt knowledge graphs to drive R&D (videos from PMWC 2020)

Pharmaceutical companies adopt knowledge graphs to drive R&D (videos from PMWC 2020)

Data4Cure joined the Precision Medicine World Conference to organize a session on semantic knowledge graphs in drug discovery and clinical trials, exploring interpretable semantic AI that combines machine learning and knowledge graphs.

Offer

Websites

Authorized Representatives

Bogusław Aleksander Kluge age 45 – President of the Management Board
Anna Małgorzata Iwińska age 44 – Vice President of the Management Board

Manner of representation

In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a management board consisting of two or more persons, each member of the management board is authorised to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Data4cure, Inc.
100$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2020-07-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Cloudimed sp. z o.o.
Dotdata Poland sp. z o.o.
Naturalantibody S.A.
Evidence Prime sp. z o.o.
Creatoriq Europe sp. z o.o.
Graylight Imaging sp. z o.o.
Easybase sp. z o.o.
Algolytics Technologies sp. z o.o.
Think Project Polska sp. z o.o.
Dicella sp. z o.o.

Change history

DateEvent
2024-03-05Address change
2020-05-28Entered in the register

FAQ

Last updated: 2026-10-07